Coronary Artery Bypass Graft Equipment
-
by XELTIS BVbased in NETHERLANDS
The XABG device is a restorative, synthetic, electrospun blood vessels for CABG surgery, overtime turning into a living vessel made of patient’s own ...
-
Manufactured by XyloCor Therapeuticsbased in USA
Coronary Artery Bypass Graft Surgery or CABG is a procedure used to treat coronary artery disease – the narrowing or blockage of the blood vessels that supply oxygen and nutrients to the heart muscle. During CABG, a healthy artery or vein from the body is connected, or ...
-
Manufactured by Celixir plcbased in UNITED KINGDOM
PHASE 2 : Our first investigational cardiac regenerative medicine consists of iMP cells. iMP cells are designed to treat patients with ischaemic heart disease – ischaemic cardiomyopathy – undergoing coronary artery bypass graft (CABG). They are injected around cardiac scar tissue via a single application during ...
-
Manufactured by Carl Zeiss Meditec AGbased in GERMANY
INFRARED 800 from ZEISS enables intraoperative visual assessment of blood flow and vessel patency during arteriovenous malformation (AVM), bypass, aneurysm and anastomosis surgery. ZEISS INFRARED 800 is indicated for use in neurosurgery, plastic and reconstructive procedures and coronary artery bypass graft ...
-
Manufactured by XyloCor Therapeuticsbased in USA
XC001 is an investigational gene therapy for the treatment of patients with refractory angina with no treatment options. Patients who have exhausted pharmacologic options and are not eligible for PCI or coronary artery bypass grafts become sedentary because of their symptoms and this can exacerbate comorbidities causing rapid ...
-
based in USA
DuraGraft®- Marizyme’ s flagship product is a first-in-class product used during Coronary Artery Bypass Grafting (CABG surgery) to help prevent vein graft failure and its complications. DuraGraft® is a biocompatible intraoperative vascular graft storage and flushing solution that ...
-
Manufactured by Mölnlycke Health Care ABbased in SWEDEN
All-in-one and split-sheet solutions for a wide variety of procedures. BARRIER® drapes for cardiovascular surgery offer effective fluid control for a dry working area. Our range includes single drapes and sets developed for cardiothoracic surgery, including heart valve replacements, pacemaker surgery, thoracotomy and coronary artery ...
-
Manufactured by Baymed Inovative Health Products Inc.based in TURKEY
drape layering. Baymed® disposable drapes for cardiovascular surgery offer effective fluid control for a dry working area. Our range includes single drapes and sets developed for cardiothoracic surgery, including heart valve replacements, pacemaker surgery, thoracotomy and coronary artery bypass ...
-
Manufactured by amg International GmbHbased in GERMANY
lesions in coronary arteries and ...
-
Manufactured by AtriCure, Inc.based in USA
The Isolator Synergy ablation clamp is the FIRST and ONLY surgical ablation device offered with FDA approval for the treatment of Atrial Fibrillation (Afib) and the only device either Catheter or Surgical to be approved for the treatment of persistent and long-standing persistent ...
-
Manufactured by Revotek Co., Ltd.based in USA
It is estimated by the World Health Organization that the current global prevalence of advanced vascular disease is ~175mm people and increasing. One of the most common clinical interventions to treat advanced vascular disease is the replacement of stenotic or occluded arteries with vascular grafts. This is often accomplished utilizing ...
-
Manufactured by Carl Zeiss Meditec AGbased in GERMANY
OPMI PENTERO 900 represents the next generation visualization system. Building on the innovations of OPMI Pentero introduced in 2004, OPMI PENTERO 900 combines award-winning design concepts and new functionalities in a proven, fully integrated platform. Key functions have been enhanced and new visualization methods integrated, raising OPMI PENTERO 900 to a high level of ...
-
Manufactured by Vascudyne, Inc.based in USA
Synthetic vascular grafts currently used in clinic have poor long term outcomes and low patency rates. Hyperplasia, calcification, foreign body immune response, infection, and atheroma formation are commonly encountered limiting the use of synthetic grafts, with none available for small diameter applications like coronary ...
-
Manufactured by Cardiovascular Systems, Inc.based in USA
At CSI, we are a culture of innovation, driven by the understanding that smart design changes, no matter how small, can make a big difference at a critical moment – a difference that may make things simpler, deliver better outcomes or even save a life. We observe carefully, listen closely and collaborate extensively, seeking opportunities to help interventionalists do their jobs more easily ...
-
Manufactured by Palisade Biobased in USA
Our lead asset LB1148 is a novel oral liquid formulation of the well-characterized digestive enzyme inhibitor, tranexamic acid (“TXA”), with potential to both reduce abdominal adhesions and help restore bowel function following surgery. The therapy is being developed for administration prior to major surgeries that are at risk of disrupting the intestinal epithelial ...
-
Manufactured by CeloNova BioSciences, Inc.based in USA
COBRA PzF NCS is the world’s first non-drug eluting, nanocoated stent that allows physicians to safely and effectively treat their patients who may benefit from a short, minimum 1-month DAPT ...
-
based in GERMANY
Tiprelestat is a pioneering anti-inflammatory and tissue protective drug being developed for the treatment of pulmonary-arterial hypertension, the prevention of serious disease progression of COVID-19 and the prevention of postoperative inflammatory ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you